Status:
COMPLETED
The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
Lead Sponsor:
Duke University
Collaborating Sponsors:
CareDx
Conditions:
Medication Compliance
Eligibility:
All Genders
12-40 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical b...
Eligibility Criteria
Inclusion
- 1\) age 12-40 kidney transplant recipients with stable kidney function at least one month from the time of transplantation
- 2\) have and use a smartphone
- 3\) patients without pre-formed antibodies
Exclusion
- 1\) Patients \<12 or \>40
- 2\) patient with pre-existing antibodies
- 3\) patients with rejection at the time of enrollment
- 4\) patients without a smartphone
- 5\) patients with developmental delay or psychological impairment and unable to use an app
Key Trial Info
Start Date :
October 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04382248
Start Date
October 15 2020
End Date
November 30 2021
Last Update
February 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University
Durham, North Carolina, United States, 27710